ASSOCIATION OF GENE POLYMORPHISMS WITH RISK OF SPORADIC PAPILLARY THYROID CARCINOMA


  • M.Zh. Espenbetova Semey Medical University, Kazakhstan
  • A.S. Krykpayeva Semey Medical University, Kazakhstan
  • Zh.K. Zamanbekova Semey Medical University, Kazakhstan
  • A. Espenbetov Semey Medical University, Kazakhstan
  • B.S. Azizov Semey Medical University, Kazakhstan
  • A.S. Abenova Semey Medical University, Kazakhstan
  • Sh.B. Bolatova Semey Medical University, Kazakhstan
  • N.E. Glushkova Semey Medical University, Kazakhstan
Keywords: thyroid gland cancer, biomarkers, single nucleotide polymorphisms

Abstract

ASSOCIATION OF GENE POLYMORPHISMS WITH RISK OF SPORADIC PAPILLARY THYROID CARCINOMA

References

1. Davies, Louise, et al. “American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer.” Endocrine Practice 21.6 (2015): 686-696.

2. He, Huiling, et al. “Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.” The Journal of Clinical Endocrinology & Metabolism 100.1 (2015): E164-E172.

3. Gudmundsson, Julius, et al. “Common variants on 9q22. 33 and 14q13. 3 predispose to thyroid cancer in European populations.” Nature genetics 41.4 (2009): 460.
Published
2019-11-07
How to Cite
Espenbetova, M., Krykpayeva, A., Zamanbekova, Z., Espenbetov, A., Azizov, B., Abenova, A., Bolatova, S., & Glushkova, N. (2019). ASSOCIATION OF GENE POLYMORPHISMS WITH RISK OF SPORADIC PAPILLARY THYROID CARCINOMA. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 42-43. https://doi.org/10.29256/v.03.01.2019.escbm25
Section
Selected abstracts